O'Shaughnessy Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10	Closed	–	–	2710
2021 Q2	$0	Buy	+10	New	+$426	﹤0.01%	2563
2021 Q1	–	Sell	-7	Closed	–	–	2365
2020 Q4	$0	Sell	7 -5,884	-100%	-$223K	﹤0.01%	2065
2020 Q3	$209K	Sell	5,891 -7,000	-54%	-$253K	0.01%	682
2020 Q2	$487K	Sell	12,891 -841	-6%	-$27.7K	0.02%	406
2020 Q1	$399K	Sell	13,732 -7,577	-36%	-$306K	0.01%	326
2019 Q4	$1.1M	Buy	21,309 +3,110	+17%	+$181K	0.02%	257
2019 Q3	$999K	Buy	+18,199	New	+$934K	0.02%	265
2018 Q3	–	Sell	-5,177	Closed	-$164K	–	898
2018 Q2	$164K	Sell	5,177 -7,559	-59%	-$311K	﹤0.01%	570
2018 Q1	$633K	Sell	12,736 -41	-0.3%	-$2.32K	0.01%	310
2017 Q4	$689K	Buy	12,777 +7,241	+131%	+$401K	0.02%	331
2017 Q3	$321K	Buy	5,536 +604	+12%	+$31.6K	0.01%	432
2017 Q2	$243K	Sell	4,932 -7,502	-60%	-$345K	0.01%	483
2017 Q1	$540K	Sell	12,434 -1,526	-11%	-$72.8K	0.01%	347
2016 Q4	$683K	Sell	13,960 -6,183	-31%	-$286K	0.02%	314
2016 Q3	$964K	Buy	20,143 +2,203	+12%	+$109K	0.02%	275
2016 Q2	$962K	Buy	17,940 +14,332	+397%	+$675K	0.02%	275
2016 Q1	$162K	Buy	+3,608	New	+$146K	﹤0.01%	485
2015 Q2	–	Sell	-8,285	Closed	-$341K	–	970
2015 Q1	$341K	Sell	8,285 -11,027	-57%	-$446K	0.01%	433
2014 Q4	$784K	Sell	19,312 -20,391	-51%	-$797K	0.02%	349
2014 Q3	$1.45M	Sell	39,703 -6,195	-13%	-$268K	0.03%	289
2014 Q2	$2.13M	Buy	45,898 +4,196	+10%	+$187K	0.04%	252
2014 Q1	$1.71M	Buy	41,702 +17,708	+74%	+$658K	0.03%	259
2013 Q4	$914K	Buy	+23,994	New	+$740K	0.02%	337